Matthias K.
- Country
- Germany
- Department
- Paediatric Pneumology
Research Overview
Data & Insights
Has run more than one trial at 0 of 68 partner sites.
Specializations
Pediatric Interstitial Lung Disease and Pulmonary Hypertension
The investigator concentrates on the diagnosis and management of interstitial lung disease and associated pulmonary hypertension in children.
- Fibrotic lung remodeling in pediatric patients
- Hemodynamic assessment of childhood pulmonary hypertension
- Biomarker development for early detection of interstitial lung disease
- Therapeutic strategies targeting vascular remodeling
These efforts aim to improve long‑term outcomes for children facing complex respiratory vascular disorders.
Severe Asthma and Atopic Disorders in Children
Focused on refractory severe asthma and related atopic conditions, the investigator evaluates novel biologic and anti‑inflammatory approaches.
- Biologic modulation of type‑2 inflammation
- Phenotyping of pediatric asthma endotypes
- Integration of biomarkers for treatment selection
- Management of comorbid atopic dermatitis and allergic rhinitis
The goal is to personalize therapy for children with uncontrolled airway disease.
Cystic Fibrosis and Bronchiectasis Management
In the realm of chronic airway infection, the investigator addresses cystic fibrosis and non‑cystic bronchiectasis in pediatric cohorts.
- Optimizing mucus clearance techniques
- Antimicrobial stewardship for chronic Pseudomonas colonization
- Evaluation of CFTR modulator impact on lung function
- Preventive strategies for bronchiectasis progression
These studies target reduction of exacerbations and preservation of lung capacity.
Lung Transplantation and Post‑Transplant Complications
The investigator contributes to the field of pediatric lung transplantation, focusing on graft survival and complications such as bronchiolitis obliterans syndrome.
- Immunologic monitoring for early rejection
- Therapeutic interventions for bronchiolitis obliterans syndrome
- Long‑term functional outcomes after transplant
- Infection prophylaxis in immunosuppressed children
Research seeks to extend graft longevity and improve quality of life post‑transplant.
Emerging Therapies for Rare Pediatric Pulmonary Conditions
Beyond common diseases, the investigator explores innovative treatments for rare pediatric pulmonary conditions such as alveolar proteinosis and genetic surfactant disorders.
- Gene‑editing approaches for surfactant protein deficiencies
- Targeted therapies for pulmonary alveolar proteinosis
- Clinical evaluation of novel inhaled agents
- Registry development for ultra‑rare lung diseases
These initiatives aim to bring precision medicine to underserved patient groups.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.